This FDA-approved prescription medication is blamed for thousands of people suffering permanent total hair loss (alopecia). Although Taxotere (docetaxel) is approved for treating other types of cancers, most victims are women who have been injected with the drug as part of their breast cancer treatment.
Drug companies Sanofi Inc., Sandoz Inc., Pfizer Inc., Accord Healthcare Inc. and others are accused of concealing the hair loss risks of Taxotere from U.S. patients for more than a decade. A 2013 study from the National Cancer Research Institute concluded that roughly 10-15% of patients experienced permanent hair loss after using Taxotere.
Taxotere/docetaxel has been linked to:
- Alopecia Areata: circular patches of hair loss
- Alopecia Totalis: total hair loss on the scalp
- Alopecia Universalis: total hair loss on the scalp and body
If you or a loved one have suffered permanent total hair loss after being prescribed Taxotere, please contact the experienced team of pharmaceutical lawyers at Allen & Nolte about how we can help you.